These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
456 related items for PubMed ID: 31830587
1. Biologics in chronic rhinosinusitis with nasal polyposis. Laidlaw TM, Buchheit KM. Ann Allergy Asthma Immunol; 2020 Apr; 124(4):326-332. PubMed ID: 31830587 [Abstract] [Full Text] [Related]
2. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives. Okano M, Kanai K, Oka A. Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131 [Abstract] [Full Text] [Related]
5. Biologics in Chronic Rhinosinusitis: Current and Emerging. Boyd JT, Khanwalkar AR. Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716 [Abstract] [Full Text] [Related]
6. The Role of Biologics in the Treatment of Nasal Polyps. Franzese CB. Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452 [Abstract] [Full Text] [Related]
11. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. Rahavi-Ezabadi S, Zhou S, Lee SE, Ference E, Magit A, Leuin S, Mohamed K, Rezaei N, Patel VA. Otolaryngol Head Neck Surg; 2024 Jul; 171(1):35-44. PubMed ID: 38488239 [Abstract] [Full Text] [Related]
12. Use of biologics in chronic sinusitis with nasal polyps. Wang C, Zhang L. Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822 [Abstract] [Full Text] [Related]
13. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis. Geng B, Dilley M, Anterasian C. Curr Allergy Asthma Rep; 2021 Jun 10; 21(6):36. PubMed ID: 34110505 [Abstract] [Full Text] [Related]
14. A Critical Look at the Efficacy and Costs of Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyposis. Brown WC, Senior B. Curr Allergy Asthma Rep; 2020 Apr 22; 20(6):16. PubMed ID: 32323067 [Abstract] [Full Text] [Related]
16. A review of phase III clinical trials of US FDA-approved biologic therapies for chronic rhinosinusitis with nasal polyposis. Lelegren MJ, Son SY, Han JK, Lam KK. Immunotherapy; 2022 Jun 22; 14(8):655-662. PubMed ID: 35510314 [Abstract] [Full Text] [Related]